MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test
At DNA Labs UAE, we offer the MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test. This test is designed to analyze the MGAT2 gene and identify any genetic variations or mutations that may be associated with glycosylation disorder type 2A.
Test Details
The MGAT2 gene is responsible for encoding an enzyme called alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase, which is involved in the glycosylation process. Glycosylation is the attachment of sugar molecules to proteins and lipids, which is essential for their proper function. A glycosylation disorder type 2A refers to a specific type of disorder that affects the glycosylation process due to mutations or variations in the MGAT2 gene. This can lead to abnormalities in the structure and function of glycoproteins and glycolipids, resulting in various clinical manifestations.
Test Components and Price
The MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card. The report will be delivered within 3 to 4 weeks.
Method and Test Type
The test is conducted using NGS (Next-Generation Sequencing) technology. NGS is a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of genetic testing, NGS can be used to analyze the MGAT2 gene and identify any genetic variations or mutations that may be associated with glycosylation disorder type 2A. The test falls under the category of metabolic disorders.
Referring Doctor and Test Department
The MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test can be requested by a General Physician. The test is conducted in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the MGAT2 Gene Glycosylation Disorder Type 2A NGS Genetic DNA Test. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with Glycosylation Disorder Type 2A.
Importance and Applications
The NGS genetic test for MGAT2 Gene Glycosylation Disorder Type 2A can help in diagnosing individuals with this specific genetic disorder. It can also provide valuable information for genetic counseling and family planning, as it can determine if an individual carries a mutation in the MGAT2 gene and may pass it on to their offspring.
It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results.
| Test Name | MGAT2 Gene Glycosylation disorder type 2A Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MGAT2 Gene Glycosylation disorder type 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2A |
| Test Details |
The MGAT2 gene is responsible for encoding an enzyme called alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase, which is involved in the glycosylation process. Glycosylation is the attachment of sugar molecules to proteins and lipids, which is essential for their proper function. A glycosylation disorder type 2A refers to a specific type of disorder that affects the glycosylation process due to mutations or variations in the MGAT2 gene. This can lead to abnormalities in the structure and function of glycoproteins and glycolipids, resulting in various clinical manifestations. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of genetic testing, NGS can be used to analyze the MGAT2 gene and identify any genetic variations or mutations that may be associated with glycosylation disorder type 2A. The NGS genetic test for MGAT2 gene glycosylation disorder type 2A involves obtaining a DNA sample, typically through a blood sample or buccal swab. The DNA is then extracted and prepared for sequencing using NGS technology. The MGAT2 gene is specifically targeted for sequencing, and the resulting genetic data is analyzed to identify any variations or mutations that may be present. The NGS genetic test for MGAT2 gene glycosylation disorder type 2A can help in diagnosing individuals with this specific genetic disorder. It can also provide valuable information for genetic counseling and family planning, as it can determine if an individual carries a mutation in the MGAT2 gene and may pass it on to their offspring. It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results. |
